Genetically Predicted Blood Pressure Across the Lifespan: Differential Effects of Mean and Pulse Pressure on Stroke Risk.


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 7 7 2020
medline: 17 4 2021
entrez: 7 7 2020
Statut: ppublish

Résumé

Hypertension is the leading risk factor for stroke. Yet, it remains unknown whether blood pressure pulsatility (pulse pressure [PP]) causally affects stroke risk independently of the steady pressure component (mean arterial pressure [MAP]). It is further unknown how the effects of MAP and PP on stroke risk vary with age and stroke cause. Using data from UK Biobank (N=408 228; 38-71 years), we selected genetic variants as instruments for MAP and PP at age ≤55 and >55 years and across age deciles. We applied multivariable Mendelian randomization analyses to explore associations with ischemic stroke, intracerebral hemorrhage, and their subtypes. Higher genetically predicted MAP was associated with higher risk of ischemic stroke and intracerebral hemorrhage across the examined age spectrum. Independent of MAP, higher genetically predicted PP only at age >55 years was further associated with higher risk of ischemic stroke (odds ratio per-SD-increment, 1.23 [95% CI, 1.13-1.34]). Among subtypes, the effect of genetically predicted MAP on large artery stroke was attenuated, whereas the effect of genetically predicted PP was augmented with increasing age. Genetically predicted MAP, but not PP, was associated with small vessel stroke and deep intracerebral hemorrhage homogeneously across age deciles. Neither genetically predicted MAP nor PP were associated with lobar intracerebral hemorrhage. Beyond an effect of high MAP at any age on ischemic and hemorrhagic stroke, our results support an independent causal effect of high PP at older ages on large artery stroke. This finding warrants further investigation for the development of stroke preventive strategies targeting pulsatility in later life.

Identifiants

pubmed: 32623925
doi: 10.1161/HYPERTENSIONAHA.120.15136
pmc: PMC7418931
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

953-961

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206589/Z/17/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203928/Z/16/Z
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RE/18/4/34215
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom

Références

Genet Epidemiol. 2013 Nov;37(7):658-65
pubmed: 24114802
J Am Coll Cardiol. 2019 Jul 23;74(3):330-341
pubmed: 31319915
Lancet Glob Health. 2018 Jun;6(6):e641-e649
pubmed: 29773120
JAMA. 2002 May 22-29;287(20):2677-83
pubmed: 12020303
Stroke. 2014 Jul;45(7):2160-236
pubmed: 24788967
Am J Hypertens. 2017 Nov 1;30(11):1093-1099
pubmed: 28655182
Stroke. 2016 Jun;47(6):1669-72
pubmed: 27143273
Ann Neurol. 2018 Dec;84(6):934-939
pubmed: 30383316
JAMA Cardiol. 2020 Jan 15;:
pubmed: 31940010
J Am Coll Cardiol. 2018 May 15;71(19):e127-e248
pubmed: 29146535
Circulation. 2010 Oct 5;122(14):1379-86
pubmed: 20855656
PLoS One. 2015 Apr 21;10(4):e0120758
pubmed: 25898129
Neurosci Biobehav Rev. 2015 Jun;53:121-30
pubmed: 25827412
Blood Press. 2007;16(4):238-45
pubmed: 17852092
Nat Commun. 2020 Jan 17;11(1):376
pubmed: 31953392
Lancet. 2016 Oct 8;388(10053):1603-1658
pubmed: 27733283
Int J Epidemiol. 2017 Dec 1;46(6):1985-1998
pubmed: 29040600
Arch Intern Med. 2001 Oct 22;161(19):2343-50
pubmed: 11606150
Neurology. 2020 Jul 28;95(4):e353-e361
pubmed: 32611631
Am J Hum Genet. 2014 Apr 3;94(4):511-21
pubmed: 24656865
Stroke. 2014 Dec;45(12):3754-832
pubmed: 25355838
Circulation. 1997 Jul 1;96(1):308-15
pubmed: 9236450
Neurology. 2012 Dec 4;79(23):2275-82
pubmed: 23175721
J Am Coll Cardiol. 2019 Jun 11;73(22):2856-2858
pubmed: 31171091
Circulation. 2009 Jan 20;119(2):243-50
pubmed: 19118251
Am J Epidemiol. 2015 Feb 15;181(4):251-60
pubmed: 25632051
Hypertension. 2018 Oct;72(4):796-805
pubmed: 30354723
Lancet. 2016 Aug 20;388(10046):761-75
pubmed: 27431356
J Hypertens. 2003 Sep;21(9):1669-76
pubmed: 12923399
Cardiovasc Res. 2016 Jun 1;110(3):298-308
pubmed: 27009176
Circulation. 2001 May 29;103(21):2579-84
pubmed: 11382727
Hypertension. 2001 Oct;38(4):953-7
pubmed: 11641316
J Am Coll Cardiol. 2016 Feb 2;67(4):392-403
pubmed: 26821627
J Hum Hypertens. 2006 Oct;20(10):765-71
pubmed: 16855624
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Nat Genet. 2018 Oct;50(10):1412-1425
pubmed: 30224653
J Am Heart Assoc. 2020 Jan 7;9(1):e014547
pubmed: 31902329
Eur Heart J. 2010 Aug;31(15):1865-71
pubmed: 20197424
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Lancet. 2016 Oct 8;388(10053):1459-1544
pubmed: 27733281
Eur Heart J. 2018 Feb 1;39(5):360-362
pubmed: 29020392
Am J Hypertens. 2013 May;26(5):636-42
pubmed: 23388832
Int J Epidemiol. 2019 Oct 1;48(5):1468-1477
pubmed: 31562522
Lancet Neurol. 2019 Jul;18(7):684-696
pubmed: 31097385
Stroke. 2008 Jul;39(7):1932-7
pubmed: 18451345
Clin Res Cardiol. 2016 Aug;105(8):677-686
pubmed: 26902972
Genet Epidemiol. 2013 Feb;37(2):136-41
pubmed: 22996348
Nat Genet. 2018 Apr;50(4):524-537
pubmed: 29531354
Nat Rev Cardiol. 2017 Oct;14(10):577-590
pubmed: 28569269

Auteurs

Marios K Georgakis (MK)

From the Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Germany (M.K.G., R.M., M.D.).

Dipender Gill (D)

Department of Biostatistics and Epidemiology, School of Public Health, Imperial College London, United Kingdom (D.G.).

Rainer Malik (R)

From the Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Germany (M.K.G., R.M., M.D.).

Athanase D Protogerou (AD)

Cardiovascular Prevention and Research Unit, Department of Pathophysiology, National and Kapodistrian University of Athens, Greece (A.D.P.).

Alastair J S Webb (AJS)

Centre for Prevention of Stroke and Dementia, Department of Clinical Neurosciences, University of Oxford, United Kingdom (A.J.S.W.).

Martin Dichgans (M)

From the Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Germany (M.K.G., R.M., M.D.).
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany (M.D.).
German Centre for Neurodegenerative Diseases (DZNE), Munich, Germany (M.D.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH